# Franco Stevanato

Type: Person

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/franco-stevanato
Canonical HTML page: https://getbiobrief.com/entity/franco-stevanato

## Recent coverage (1 stories)

### GLP-1 Surge Powers Stevanato Growth as Pulmonx Navigates Sales Restructuring
2026-03-05 00:20:39 · Sentiment: Positive · Impact: 6/10 · Sources: 14

Stevanato Group reported a 50% surge in GLP-1 related revenue for 2025, underscoring the massive impact of the weight-loss drug market on pharmaceutical supply chains. Conversely, medical device maker Pulmonx is undergoing a significant transition following a 50% turnover in its sales organization and a dip in U.S. quarterly revenue.
Full story: https://getbiobrief.com/story/stevanato-pulmonx-q4-2025-earnings-analysis

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.